NEW YORK (Reuters Health) – Among adult patients being treated for hematologic malignancies and who are at high risk for tumor lysis syndrome with hyperuricemia, intravenous rasburicase does a better job than oral allopurinol in controlling plasma uric acid levels, according to a new study.
“This drug...